We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$53.5B
AUM Growth
+$2.24B
Cap. Flow
+$1.79B
Cap. Flow %
3.35%
Top 10 Hldgs %
23.62%
Holding
1,680
New
114
Increased
890
Reduced
598
Closed
75

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$82.7M
2
NFLX icon
Netflix
NFLX
+$49.4M
3
ZTS icon
Zoetis
ZTS
+$47.5M
4
ONTO icon
Onto Innovation
ONTO
+$41.8M
5
TMO icon
Thermo Fisher Scientific
TMO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 25.43%
2 Financials 14.36%
3 Consumer Discretionary 10.74%
4 Healthcare 10%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDOG icon
601
Datadog
DDOG
$94B
$11.9M 0.02%
82,993
+9,097
+12% +$1.25M
CHTR icon
602
Charter Communications
CHTR
$17.3B
$11.8M 0.02%
34,503
-1,026
-3% -$371K
BMI icon
603
Badger Meter
BMI
$3.87B
$11.8M 0.02%
55,617
-527
-0.9% -$115K
WRBY icon
604
Warby Parker
WRBY
$3.19B
$11.8M 0.02%
486,212
+19,799
+4% +$404K
VRT icon
605
Vertiv
VRT
$85.7B
$11.8M 0.02%
103,486
-24,965
-19% -$2.96M
INTC icon
606
Intel
INTC
$413B
$11.6M 0.02%
580,122
+261,264
+82% +$5.89M
GSK icon
607
GSK
GSK
$107B
$11.6M 0.02%
343,334
-157,161
-31% -$5.66M
RRR icon
608
Red Rock Resorts
RRR
$3.84B
$11.6M 0.02%
251,071
+31,795
+14% +$1.62M
HBAN icon
609
Huntington Bancshares
HBAN
$34B
$11.6M 0.02%
712,704
-4,525
-0.6% -$74.4K
PODD icon
610
Insulet
PODD
$11.8B
$11.6M 0.02%
44,371
+11,210
+34% +$2.82M
MTRN icon
611
Materion
MTRN
$3.94B
$11.5M 0.02%
116,735
-4,078
-3% -$443K
COHR icon
612
Coherent
COHR
$43.4B
$11.5M 0.02%
121,835
+1,885
+2% +$189K
SYF icon
613
Synchrony
SYF
$24.4B
$11.5M 0.02%
177,550
-7,027
-4% -$430K
DT icon
614
Dynatrace
DT
$12.7B
$11.5M 0.02%
211,739
+27,616
+15% +$1.51M
CBT icon
615
Cabot Corp
CBT
$4.72B
$11.3M 0.02%
124,079
+8,068
+7% +$867K
CCK icon
616
Crown Holdings
CCK
$13B
$11.2M 0.02%
135,149
-35,931
-21% -$3.27M
TEVA icon
617
Teva Pharmaceuticals
TEVA
$40.4B
$11.1M 0.02%
504,534
+335,667
+199% +$6.11M
ENB icon
618
Enbridge
ENB
$120B
$11M 0.02%
260,385
+67,343
+35% +$2.82M
GPC icon
619
Genuine Parts
GPC
$17.9B
$11M 0.02%
94,187
-26,916
-22% -$3.36M
VV icon
620
Vanguard Large-Cap ETF
VV
$51.2B
$11M 0.02%
40,660
+4,685
+13% +$1.27M
CRUS icon
621
Cirrus Logic
CRUS
$6.76B
$10.9M 0.02%
109,965
+8,459
+8% +$929K
ALLE icon
622
Allegion
ALLE
$13.5B
$10.9M 0.02%
83,767
-26,766
-24% -$3.79M
CLX icon
623
Clorox
CLX
$12B
$10.9M 0.02%
67,296
+3,820
+6% +$625K
FOXA icon
624
Fox Class A
FOXA
$24.8B
$10.9M 0.02%
224,697
+7,878
+4% +$355K
NSIT icon
625
Insight Enterprises
NSIT
$3.85B
$10.9M 0.02%
71,538
-7,023
-9% -$1.25M

Similar funds

Natixis Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Natixis Advisors held 1,680 positions worth $53.5B, up 4.4% from $51.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Natixis Advisors deployed $1.79B of net new capital in Q4 2024, opening 114 new positions and adding to 890 existing holdings. Its largest new stake was Expand Energy Corp: 464,963 shares worth $46.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $82.7M trimmed.

  • Natixis Advisors's largest Q4 2024 buy was Expand Energy Corp: 464,963 shares worth $46.3M.
  • Natixis Advisors added most to Vanguard Growth ETF in Q4 2024, an estimated $161M increase.
  • Natixis Advisors's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $82.7M.
  • Natixis Advisors fully exited Janus International in Q4 2024, selling an estimated $10.1M.
  • Natixis Advisors's ten largest holdings make up 24% of its $53.5B portfolio in Q4 2024.
  • Natixis Advisors opened 114 new positions and closed 75 in Q4 2024.
  • Natixis Advisors's portfolio value rose 4.4% quarter-over-quarter to $53.5B.

Based on Natixis Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.